Related Experiment Video
Updated: Aug 19, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target
1Department of Pathology, Tokyo Medical University, Shinjuku-ku, Tokyo 160-8402, Japan. kuroda@tokyo-med.ac.jp
Abstract:
Here we show that human papillomavirus (HPV) E6 and E7 oncoproteins induce hWAPL expression. In addition, small interfering RNA (siRNA) of hWAPL suppressed the growth of tumours derived from SiHa cells in nude mice. Thus, hWAPL may be one of the effective targets of uterine cervical cancer therapy.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
Mechanisms of Retrovirus-induced Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Induced Pluripotent Stem Cells
Somatic cells are...

